However, in both cancer types, when patients were dichotomized into macrophage-rich versus macrophage-low groups, high TRAIL expression positively correlated with longer overall survival of patients in the cases with high tumor macrophage content, but not in low macrophage content. The gene discussed is TNFSF10; the disease is cancer.